ALPHAVEST ACQUISITION CORP (ATMV) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ATMV • KYG0283A1085

10.3 USD
+2.46 (+31.3%)
At close: Dec 9, 2025
8.26 USD
-2.04 (-19.81%)
After Hours: 12/9/2025, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

0

Taking everything into account, ATMV scores 0 out of 10 in our fundamental rating. ATMV was compared to 0 industry peers in the Unkown industry. ATMV may be in some trouble as it scores bad on both profitability and health. ATMV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ATMV had negative earnings in the past year.
  • ATMV had a positive operating cash flow in the past year.
ATMV Yearly Net Income VS EBIT VS OCF VS FCFATMV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M 2M

1.2 Ratios

Industry RankSector Rank
ROA -11.3%
ROE -15.65%
ROIC N/A
ROA(3y)5.04%
ROA(5y)N/A
ROE(3y)5.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATMV Yearly ROA, ROE, ROICATMV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 5 10

1.3 Margins

  • ATMV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATMV Yearly Profit, Operating, Gross MarginsATMV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ATMV has less shares outstanding
  • The debt/assets ratio for ATMV is higher compared to a year ago.
ATMV Yearly Shares OutstandingATMV Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M
ATMV Yearly Total Debt VS Total AssetsATMV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ATMV has an Altman-Z score of 2.46. This is not the best score and indicates that ATMV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ATMV has a debt to FCF ratio of 35.41. This is a negative value and a sign of low solvency as ATMV would need 35.41 years to pay back of all of its debts.
  • ATMV has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 35.41
Altman-Z 2.46
ROIC/WACCN/A
WACCN/A
ATMV Yearly LT Debt VS Equity VS FCFATMV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.00 indicates that ATMV may have some problems paying its short term obligations.
  • ATMV has a Quick Ratio of 0.00. This is a bad value and indicates that ATMV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
ATMV Yearly Current Assets VS Current LiabilitesATMV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for ATMV have decreased strongly by -267.99% in the last year.
EPS 1Y (TTM)-267.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1059.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ATMV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATMV Price Earnings VS Forward Price EarningsATMV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 641.51
EV/EBITDA N/A
ATMV Per share dataATMV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ATMV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALPHAVEST ACQUISITION CORP

NASDAQ:ATMV (12/9/2025, 8:00:00 PM)

After market: 8.26 -2.04 (-19.81%)

10.3

+2.46 (+31.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-28
Earnings (Next)04-13
Inst Owners41.14%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap33.17M
Revenue(TTM)N/A
Net Income(TTM)-2.14M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 641.51
P/OCF 641.51
P/B 2.42
P/tB 2.42
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.16%
OCF(TTM)0.02
OCFY0.16%
SpS0
BVpS4.25
TBVpS4.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.3%
ROE -15.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)5.04%
ROA(5y)N/A
ROE(3y)5.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 35.41
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 2.46
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-267.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1059.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-358.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.62%
OCF growth 3YN/A
OCF growth 5YN/A

ALPHAVEST ACQUISITION CORP / ATMV FAQ

What is the fundamental rating for ATMV stock?

ChartMill assigns a fundamental rating of 0 / 10 to ATMV.


What is the valuation status of ALPHAVEST ACQUISITION CORP (ATMV) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALPHAVEST ACQUISITION CORP (ATMV). This can be considered as Overvalued.


How profitable is ALPHAVEST ACQUISITION CORP (ATMV) stock?

ALPHAVEST ACQUISITION CORP (ATMV) has a profitability rating of 0 / 10.


Can you provide the financial health for ATMV stock?

The financial health rating of ALPHAVEST ACQUISITION CORP (ATMV) is 1 / 10.